UroGen Pharma Ltd. (URGN) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 44 Form 4 transactions for UroGen Pharma Ltd. (URGN) over the past 18 months (most recent 2026-09-09). Recent activity: Schoenberg Mark (Chief Medical Officer) Buy 1,667 shares, Smith Jason Drew (General Counsel) Buy 3,334 shares, Schoenberg Mark (Chief Medical Officer) Sell 871 shares, Smith Jason Drew (General Counsel) Sell 1,519 shares, Robinson James A. Jr. (Director) Buy 2,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-09Schoenberg MarkChief Medical OfficerBuy1,667$0
2026-09-09Smith Jason DrewGeneral CounselBuy3,334$0
2026-09-09Schoenberg MarkChief Medical OfficerSell871$37,383
2026-09-09Smith Jason DrewGeneral CounselSell1,519$64,618
2026-08-28Robinson James A. Jr.DirectorBuy2,000$0
2026-08-24Schoenberg MarkChief Medical OfficerSell60,677$2.9M
2026-07-10Schoenberg MarkChief Medical OfficerSell10,000$400,000
2026-06-24Schoenberg MarkChief Medical OfficerSell10,000$350,100
2026-06-09Schoenberg MarkChief Medical OfficerBuy10,000$0
2026-06-09Schoenberg MarkChief Medical OfficerSell5,222$142,561
2026-05-27Robinson James A. Jr.DirectorBuy2,000$0
2026-05-11Schoenberg MarkChief Medical OfficerSell10,000$300,000
2026-02-27Robinson James A. Jr.DirectorBuy2,000$0
2026-02-11Smith Jason DrewGeneral CounselBuy5,500$0
2026-02-11Smith Jason DrewGeneral CounselSell2,654$52,257
2026-02-11Smith Jason DrewGeneral CounselBuy3,333$0
2026-02-11Smith Jason DrewGeneral CounselSell1,608$31,662
2026-02-11Smith Jason DrewGeneral CounselBuy6,667$0
2026-02-11Smith Jason DrewGeneral CounselSell3,217$63,343
2026-02-04Schoenberg MarkChief Medical OfficerSell1,844$36,308
2026-02-04Schoenberg MarkChief Medical OfficerSell1,843$36,289
2026-02-04Schoenberg MarkChief Medical OfficerSell3,686$72,577
2026-02-03Schoenberg MarkChief Medical OfficerBuy3,334$0
2026-02-03Schoenberg MarkChief Medical OfficerBuy3,333$0
2026-02-03Schoenberg MarkChief Medical OfficerBuy6,666$0

来源:SEC Form 4 申报文件 · 截至 2026-09-09